102 related articles for article (PubMed ID: 1327032)
1. Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines.
Gazdar AF; Kadoyama C; Venzon D; Park JG; Tsai CM; Linnoila RI; Mulshine JL; Ihde DC; Giaccone G
J Natl Cancer Inst Monogr; 1992; (13):191-6. PubMed ID: 1327032
[TBL] [Abstract][Full Text] [Related]
2. Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.
Shaw GL; Gazdar AF; Phelps R; Linnoila RI; Ihde DC; Johnson BE; Oie HK; Pass HI; Steinberg SM; Ghosh BC
Cancer Res; 1993 Nov; 53(21):5181-7. PubMed ID: 8221655
[TBL] [Abstract][Full Text] [Related]
3. In vitro chemosensitivity of human lung cancer cell lines.
Ruckdeschel JC; Carney DN; Oie HK; Russell EK; Gazdar AF
Cancer Treat Rep; 1987; 71(7-8):697-704. PubMed ID: 3038314
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic characterization of neuroendocrine lung cancer cell lines.
Lai SL; Brauch H; Knutsen T; Johnson BE; Nau MM; Mitsudomi T; Tsai CM; Whang-Peng J; Zbar B; Kaye FJ
Anticancer Res; 1995; 15(2):225-32. PubMed ID: 7762988
[TBL] [Abstract][Full Text] [Related]
5. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
6. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Strassheim D; Shafer SH; Phelps SH; Williams CL
Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers.
Pujol JL; Simony J; Laurent JC; Richer G; Mary H; Bousquet J; Godard P; Michel FB
Cancer Res; 1989 May; 49(10):2797-802. PubMed ID: 2540908
[TBL] [Abstract][Full Text] [Related]
8. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition by cholera toxin of human lung carcinoma cell lines: correlation with GM1 ganglioside expression.
Kaur G; Viallet J; Laborda J; Blair O; Gazdar AF; Minna JD; Sausville EA
Cancer Res; 1992 Jun; 52(12):3340-6. PubMed ID: 1375868
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations.
Georgiadis MS; Russell EK; Gazdar AF; Johnson BE
Clin Cancer Res; 1997 Mar; 3(3):449-54. PubMed ID: 9815704
[TBL] [Abstract][Full Text] [Related]
11. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1.
Walker GE; Antoniono RJ; Ross HJ; Paisley TE; Oh Y
Oncogene; 2006 Mar; 25(13):1943-54. PubMed ID: 16302002
[TBL] [Abstract][Full Text] [Related]
14. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
16. In vitro chemosensitivity testing of human non-small cell lung cancer cell lines.
Bepler G; O'Briant K
Anticancer Res; 1998; 18(5A):3181-5. PubMed ID: 9858881
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation in lung cancer.
Carey FA; Save VE
J Pathol; 1997 May; 182(1):9-10. PubMed ID: 9227335
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer.
Petrović M; Baskić D; Banković D; Ilić N
Biomarkers; 2011 Jun; 16(4):311-20. PubMed ID: 21595568
[TBL] [Abstract][Full Text] [Related]
19. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
Poola I; Graziano SL
J Exp Clin Cancer Res; 1998 Jun; 17(2):165-73. PubMed ID: 9700577
[TBL] [Abstract][Full Text] [Related]
20. Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy.
Zeng-Rong N; Paterson J; Alpert L; Tsao MS; Viallet J; Alaoui-Jamali MA
Cancer Res; 1995 Nov; 55(21):4760-4. PubMed ID: 7585500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
